Mobile Critical Care Recovery Program for Survivors of Acute Respiratory Failure

Babar A. Khan,Anthony J. Perkins,Sikandar Hayat Khan,Frederick W. Unverzagt,Sue Lasiter,Sujuan Gao,Sophia Wang,Ben L. Zarzaur,Omar Rahman,Ahmed Eltarras,Hadi Qureshi,Malaz A. Boustani
DOI: https://doi.org/10.1001/jamanetworkopen.2023.53158
2024-02-01
JAMA Network Open
Abstract:Importance Over 50% of Acute Respiratory Failure (ARF) survivors experience cognitive, physical, and psychological impairments that negatively impact their quality of life (QOL). Objective To evaluate the efficacy of a post–intensive care unit (ICU) program, the Mobile Critical Care Recovery Program (m-CCRP) consisting of a nurse care coordinator supported by an interdisciplinary team, in improving the QOL of ARF survivors. Design, Setting, and Participants This randomized clinical trial with concealed outcome assessments among ARF survivors was conducted from March 1, 2017, to April 30, 2022, with a 12-month follow-up. Patients were admitted to the ICU services of 4 Indiana hospitals (1 community, 1 county, 2 academic), affiliated with the Indiana University School of Medicine. Intervention A 12-month nurse-led collaborative care intervention (m-CCRP) supported by an interdisciplinary group of clinicians (2 intensivists, 1 geriatrician, 1 ICU nurse, and 1 neuropsychologist) was compared with a telephone-based control. The intervention comprised longitudinal symptom monitoring coupled with nurse-delivered care protocols targeting cognition, physical function, personal care, mobility, sleep disturbances, pain, depression, anxiety, agitation or aggression, delusions or hallucinations, stress and physical health, legal and financial needs, and medication adherence. Main Outcomes and Measures The primary outcome was QOL as measured by the 36-item Medical Outcomes Study Short Form Health Survey (SF-36) physical component summary (PCS) and mental component summary (MCS), with scores on each component ranging from 0-100, and higher scores indicating better health status. Results In an intention-to-treat analysis among 466 ARF survivors (mean [SD] age, 56.1 [14.4] years; 250 [53.6%] female; 233 assigned to each group), the m-CCRP intervention for 12 months did not significantly improve the QOL compared with the control group (estimated difference in change from baseline between m-CCRP and control group: 1.61 [95% CI, −1.06 to 4.29] for SF-36 PCS; −2.50 [95% CI, −5.29 to 0.30] for SF-36 MCS. Compared with the control group, the rates of hospitalization were higher in the m-CCRP group (117 [50.2%] vs 95 [40.8%]; P = .04), whereas the 12-month mortality rates were not statistically significantly lower (24 [10.3%] vs 38 [16.3%]; P = .05). Conclusions and Relevance Findings from this randomized clinical trial indicated that a nurse-led 12-month comprehensive interdisciplinary care intervention did not significantly improve the QOL of ARF survivors after ICU hospitalization. These results suggest that further research is needed to identify specific patient groups who could benefit from tailored post-ICU interventions. Trial Registration ClinicalTrials.gov Identifier:NCT03053245
medicine, general & internal
What problem does this paper attempt to address?
### Problems the Paper Aims to Address This paper aims to evaluate the effectiveness of a program called the "Mobile Critical Care Rehabilitation Program" (m-CCRP) in improving the quality of life for survivors of acute respiratory failure (ARF). Specifically, the study's goal is to assess whether the m-CCRP, led by a nurse coordinator and supported by an interdisciplinary team, can significantly enhance the quality of life for ARF survivors. ### Research Background and Objectives - **Background**: More than 50% of ARF survivors experience cognitive, physical, and psychological impairments, which negatively impact their quality of life. - **Objective**: To evaluate whether the m-CCRP can improve the quality of life for ARF survivors by providing continuous symptom monitoring and care protocols. ### Key Findings - **Results**: The study results indicate that during the 12-month intervention period, the m-CCRP did not significantly improve the quality of life for ARF survivors. - **Secondary Findings**: - There were no significant differences in symptoms of depression and anxiety. - Cognitive function did not show significant improvement. - The readmission rate was slightly higher in the m-CCRP group, but the 12-month mortality rate showed no significant difference. ### Conclusion The study results suggest that a 12-month comprehensive interdisciplinary care intervention led by nurses did not significantly improve the quality of life for ARF survivors post-ICU discharge. This indicates the need for further research to identify which specific patient groups might benefit from such interventions.